NewsCentanafadine: First Triple Reuptake Inhibitor for ADHD Nears FDA Approval
An overview of centanafadine, a novel triple reuptake inhibitor for ADHD, covering its mechanism, clinical trials, safety, FDA status, and comparison with existing therapies.